Friday
SESSION 74: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION (TCAR)
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
Moderators:Frank J. Veith, MD / Klaus D. Mathias, MD  
SESSION 74 SCHEDULE
MESH COVERED STENTS
7:50 AM - 7:55 AM

Power Point Presentation with Synched Audio
Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter
  Presenter(s):Max Amor, MD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
7:56 AM - 8:01 AM Advantages And Limitations Of Mesh Covered Stents In CAS: Are They Really Better
  Presenter(s):Laura Capoccia, MD, PhD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
8:02 AM - 8:07 AM

Power Point Presentation with Synched Audio
7-Year Experience With Micromesh Stents For CAS: Are There Downsides (Thrombosis Or ISR): Technical Tips To Optimize Their Results
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
8:08 AM - 8:13 AM New Multicenter Data Showing The Long-Term Value Of The C-Guard Micronet Mesh Covered Stent For CAS In High Risk Carotid Lesions (Thrombotic, Calcified And Symptomatic) From The Flow-Guard And Other Trials
  Presenter(s):Piotr Musialek, MD, DPhil / D. Christopher Metzger, MD   
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
TCAR RELATED TOPICS
8:14 AM - 8:19 AM TCAR Versus CEA (Carotid Endarterectomy): A Propensity Matched SVS VQI Study: 1-Year Results Show Equal Stroke/Death Rates And Decreased Cranial Nerve Injuries With TCAR: Findings Also Confirmed By A Meta-Analysis
  Presenter(s):Mahmoud B. Malas, MD, MHS / Marc L. Schermerhorn, MD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
8:20 AM - 8:25 AM TCAR Versus Transfemoral CAS (TFCAS): A Propensity Matched SVS VQI Study Shows That TCAR Has Lower Stroke And Death Rates Than TFCAS
  Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS / Vikram S. Kashyap, MD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
8:26 AM - 8:31 AM Why I Am Uncertain That TCAR Will Have Better Outcomes Than TFCAS: What Does The CREST 2 Registry Show
  Presenter(s):Thomas G. Brott, MD / William A. Gray, MD / 
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
8:32 AM - 8:37 AM DEBATE: For TFCAS Reversal Or Cessation Of Flow With The Gore Or MoMA Device Cerebral Embolic Protection Is No Better Than Filter Protection: Why Is This So
  Presenter(s):Marc L. Schermerhorn, MD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
8:38 AM - 8:43 AM DEBATE: Not So: In Some Specific Circumstances Reversal Or Cessation Of Flow Protection During TFCAS Is Better And Safer Than Filter Protection
  Presenter(s):William A. Gray, MD / 
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
8:44 AM - 8:49 AM Based On Data To Date When Should TCAR Replace CEA And When Should It Not: A Balanced View
  Presenter(s):Vikram S. Kashyap, MD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
8:50 AM - 8:55 AM TCAR Seems Better Than TFCAS And Equal To CEA: It Has A Bright Future: What Are Its Drawbacks
  Presenter(s):Wesley S. Moore, MD  
Location: LECTURE HALL 1 - BONNET CREEK BALLROOM
  View Slides in PDF      
8:56 AM - 9:04 AM Panel Discussion
9:04 AM - 9:17 AM Break Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 74
previous next